MeSH tree: C18.452.648.618
When we think about iron imbalance, most people are familiar with iron deficiency and the health problems it can cause. What many may not realize is that the opposite problem, iron overload, can be just as serious—yet many ...
Feb 7, 2026
0
11
People from the Outer Hebrides and north-west Ireland have the highest risk of developing a genetic disease that causes a dangerous build-up of iron in the body, a study published in the journal Nature Communications suggests.
Feb 3, 2026
0
61
The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for Menkes disease in pediatric patients. Approval of Zycubo was granted to Sentynl Therapeutics.
Jan 21, 2026
0
7
A new study from Karolinska University Hospital and Karolinska Institutet in collaboration with Uppsala University Hospital and Uppsala University shows suspected small vessel disease in young patients with Wilson's disease. ...
Jan 7, 2026
0
8
In 1962, a pediatric neurology resident at Columbia's Neurological Institute and his colleagues in the College of Physicians and Surgeons published a detailed paper in Pediatrics describing a new syndrome of neurodegeneration ...
Oct 30, 2025
0
18
A research team led by Prof. Li Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has developed a novel deep learning framework that significantly improves the accuracy and interpretability ...
Jul 7, 2025
0
19
New research has found that men who carry a common genetic variant are twice as likely to develop dementia in their lifetime compared to women.
May 30, 2025
0
62
Hypophosphatasia is a relatively common skeletal disease that primarily affects bone and tooth strength. In the third national dental survey of hypophosphatasia in Japan, recently published in Scientific Reports, researchers ...
Mar 10, 2025
0
16
Thousands of people globally with an iron disorder have their blood regularly thrown out—Australian research shows it can be used to save lives
Feb 18, 2025
0
142
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three to six times each week.
Feb 3, 2025
0
62
